LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "aml cells" as a keyword



Exosome‐Shuttled METTL14 From AML‐Derived Mesenchymal Stem Cells Promotes the Proliferation and Radioresistance in AML Cells by Stabilizing ROCK1 Expression via an m6A‐IGF2BP3‐Dependent Mechanism

Sign Up to like & get
recommendations! Published in 2024 at "Drug Development Research"

DOI: 10.1002/ddr.70025

Abstract: Acute myelogenous leukemia (AML)‐derived mesenchymal stem cells (MSCs) (AML‐MSCs) have been identified to play a significant role in AML progression. The functions of MSCs mainly depend on their paracrine action. Here, we investigated whether AML‐MSCs… read more here.

Keywords: m6a; aml; radioresistance; aml mscs ... See more keywords

Chemoresistance in acute myeloid leukemia: An alternative single-cell RNA sequencing approach.

Sign Up to like & get
recommendations! Published in 2023 at "Hematological oncology"

DOI: 10.1002/hon.3129

Abstract: Our previous study demonstrated that myc, mitochondrial oxidative phosphorylation, mTOR, and stemness are independently responsible for chemoresistance in acute myeloid leukemia (AML) cells. This study aimed to identify potential mechanisms of chemoresistance of the "7+3"… read more here.

Keywords: cell; chemoresistance acute; rna; aml cells ... See more keywords

RNF38 promotes gilteritinib resistance in acute myeloid leukemia via inducing autophagy by regulating ubiquitination of LMX1A

Sign Up to like & get
recommendations! Published in 2024 at "Cell Biology and Toxicology"

DOI: 10.1007/s10565-024-09936-8

Abstract: Gilteritinib is a commonly used targeted drug for acute myeloid leukemia (AML), but the emergence of gilteritinib resistance greatly reduces the therapeutic effect. RING finger protein 38 (RNF38), a protein with RING Finger domain and… read more here.

Keywords: gilteritinib resistance; resistance; aml cells; lmx1a ... See more keywords

4-Hydroxyphenyl Retinamide Preferentially Targets FLT3 Mutated Acute Myeloid Leukemia via ROS Induction and NF-κB Inhibition

Sign Up to like & get
recommendations! Published in 2020 at "Current Medical Science"

DOI: 10.1007/s11596-020-2259-0

Abstract: FMS-like tyrosine kinase 3 (FLT3) mutation is strongly associated with poor prognosis in acute myeloid leukemia (AML). Though many FLT3 inhibitors have been developed for clinical application with 34%–56% complete remission rate, patients would develop… read more here.

Keywords: hydroxyphenyl retinamide; myeloid leukemia; flt3 mutated; aml cells ... See more keywords

Acute Myelogenous Leukemia Cells Secrete Factors that Stimulate Cellular LDL Uptake via Autocrine and Paracrine Mechanisms

Sign Up to like & get
recommendations! Published in 2017 at "Lipids"

DOI: 10.1007/s11745-017-4256-z

Abstract: Leukemic cells isolated from most patients with acute myelogenous leukemia (AML) have higher low density lipoprotein (LDL) uptake than normal mononuclear blood cells. Little is known, however, about the mechanism behind the elevated LDL uptake.… read more here.

Keywords: ldl uptake; ldl degradation; cells secrete; aml cells ... See more keywords

Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia.

Sign Up to like & get
recommendations! Published in 2021 at "Cellular oncology"

DOI: 10.1007/s13402-021-00621-0

Abstract: PURPOSE Despite great advances that have been made in the understanding of the molecular complexity of acute myeloid leukemia (AML), very little has been translated into new therapies. Here, we set out to investigate the… read more here.

Keywords: cytoskeleton regulatory; regulatory genes; myeloid leukemia; aml cells ... See more keywords

Typhaneoside prevents acute myeloid leukemia (AML) through suppressing proliferation and inducing ferroptosis associated with autophagy.

Sign Up to like & get
recommendations! Published in 2019 at "Biochemical and biophysical research communications"

DOI: 10.1016/j.bbrc.2019.06.070

Abstract: Leukemia remains a fatal disease for most patients and effective therapeutic strategies are urgently required. Typhaneoside (TYP) is a major flavonoid in the extract of Pollen Typhae, showing significant biological and pharmacological effects. In the… read more here.

Keywords: myeloid leukemia; aml cells; ferroptosis; acute myeloid ... See more keywords

3058 – SURFACE PROTEOMICS REVEALS NOVEL POTENTIAL AML ANTIGENS FOR IMMUNOTHERAPEUTIC TARGETING

Sign Up to like & get
recommendations! Published in 2020 at "Experimental Hematology"

DOI: 10.1016/j.exphem.2020.09.075

Abstract: Compared to solid tumors, antibody-based immunotherapy is underexploited in acute myeloid leukemia (AML), likely due to the limited availability of targetable surface antigens specifically expressed on AML cells. While targeted immunotherapies hold great promise, their… read more here.

Keywords: aml subgroups; aml cells; 3058 surface; aml ... See more keywords
Photo from archive.org

miR-155 as a potential target of IL-3 signaling in primary AML cells.

Sign Up to like & get
recommendations! Published in 2017 at "Leukemia research"

DOI: 10.1016/j.leukres.2017.02.010

Abstract: miR-155 has emerged as one of the key microRNAs (miRNAs) involved in normal and malignant myelopoiesis, and high expression of this miRNA has been flagged as a strong independent prognostic marker in Acute Myeloid Leukemia… read more here.

Keywords: mir 155; target signaling; primary aml; aml cells ... See more keywords

Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells

Sign Up to like & get
recommendations! Published in 2019 at "Experimental Cell Research"

DOI: 10.1016/j.yexcr.2019.02.008

Abstract: &NA; Relapse of minimal residual disease (MRD) is a major problem after conventional chemotherapy in patients with acute myeloid leukemia (AML). The bone marrow stroma can protect AML cells from insults of chemotherapy, partly contributing… read more here.

Keywords: ato; aml cells; acute myeloid; leukemia ... See more keywords

Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells

Sign Up to like & get
recommendations! Published in 2017 at "Oncogene"

DOI: 10.1038/onc.2016.310

Abstract: Resistance to apoptosis, for example due to overexpression of Inhibitor of Apoptosis (IAP) proteins, is associated with poor prognosis in acute myeloid leukemia (AML). Here, we identify that Smac mimetics such as BV6, which antagonizes… read more here.

Keywords: apoptosis resistance; myeloid leukemia; necroptosis; aml cells ... See more keywords